Owens & Minor Reports Second Quarter 2023 Financial Results
Owens & Minor, Inc. reported financial results for the second quarter ended June 30, 2023.
Owens & Minor Reports Second Quarter 2023 Financial Results Read More »
Uncategorized
Zomedica to Host Second Quarter Financial Results Call on August 10, 2023
Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Thursday, August 10, 2023 at 4:30 p.m. ET to discuss the Company’s operational and financial highlights for its second quarter ending June 30, 2023.
Zomedica to Host Second Quarter Financial Results Call on August 10, 2023 Read More »
Amneal Reports Second Quarter 2023 Financial Results
Amneal Pharmaceuticals, Inc. announced its results for the second quarter ended June 30, 2023.
Amneal Reports Second Quarter 2023 Financial Results Read More »
Novo Nordisk, Lilly Sued Over Stomach Paralysis Allegations Regarding GLP-1 Drugs
A Louisiana woman has filed a lawsuit alleging that Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro did not have warnings about the risk of severe gastrointestinal problems.
Novo Nordisk, Lilly Sued Over Stomach Paralysis Allegations Regarding GLP-1 Drugs Read More »
El refugio atómico: Un vistazo a sus componentes y su importancia en la seguridad nuclear
La seguridad y protección ante situaciones de emergencia nuclear se han vuelto una preocupación primordial. Entre las medidas tomadas para garantizar la seguridad de las personas, el refugio atómico se destaca como una opción confiable. Conozcamos los componentes esencial …
El origen de las razas humanas: Explorando la diversidad genética
La diversidad humana es un fenómeno fascinante y complejo. A lo largo de la historia, los seres humanos se han desarrollado y adaptado a una variedad de entornos y condiciones, dando lugar a la aparición de diferentes rasgos físicos y culturales en las poblaciones de todo el mun …
El origen de las razas humanas: Explorando la diversidad genética Read More »
Sistemas para fechar el pasado: Desvelando los misterios de la historia
La capacidad de conocer y comprender el pasado ha sido una de las búsquedas más apasionantes de la humanidad. A través de métodos científicos y tecnológicos avanzados, los investigadores han desarrollado diversos sistemas para fechar el pasado, permiti&eacut …
Sistemas para fechar el pasado: Desvelando los misterios de la historia Read More »
Sosei Heptares Operational Highlights and Consolidated Results for the Second Quarter and First Half of 2023
Sosei Group Corporation provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2023.
Basilea announces submission of a New Drug Application to the US Food and Drug Administration for its antibiotic ceftobiprole
Basilea Pharmaceutica Ltd, Allschwil, a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced that it has submitted a New Drug Application to the US Food and Drug Administration.
Mesoblast Receives Complete Response From U.S. Food and Drug Administration for Biologics License Application for Steroid-Refractory Acute Graft Versus Host Disease in Children
Mesoblast Limited announced that the US Food and Drug Administration has provided a complete response to its Biologics License Application resubmission for remestemcel-L for the treatment of pediatric steroid-refractory acute graft versus host disease and requires more data to support marketing approval.